These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 7493614

  • 1. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
    Gnanalingham KK, Milkowski NA, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):235-41. PubMed ID: 7493614
    [Abstract] [Full Text] [Related]

  • 2. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Synapse; 1993 Jun 24; 14(2):184-94. PubMed ID: 8332947
    [Abstract] [Full Text] [Related]

  • 3. Alteration of neurotensin receptors in MPTP-treated mice.
    Tanji H, Araki T, Fujihara K, Nagasawa H, Itoyama Y.
    Peptides; 1999 Jun 24; 20(7):803-7. PubMed ID: 10477079
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset.
    Mackenzie GM, Jackson MJ, Jenner P, Marsden CD.
    Synapse; 1997 Jul 24; 26(3):301-16. PubMed ID: 9183819
    [Abstract] [Full Text] [Related]

  • 5. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA, Rothblat DS, Joyce JN, Schneider JS.
    Synapse; 1995 Jan 24; 19(1):46-55. PubMed ID: 7709343
    [Abstract] [Full Text] [Related]

  • 6. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
    Robertson RG, Clarke CA, Boyce S, Sambrook MA, Crossman AR.
    Brain Res; 1990 Oct 29; 531(1-2):95-104. PubMed ID: 2289139
    [Abstract] [Full Text] [Related]

  • 7. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 29; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 8. Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosets.
    Rose S, Nomoto M, Jackson EA, Gibb WR, Jenner P, Marsden CD.
    Neuropharmacology; 1989 Nov 29; 28(11):1211-6. PubMed ID: 2512516
    [Abstract] [Full Text] [Related]

  • 9. Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.
    Alexander GM, Schwartzman RJ, Brainard L, Gordon SW, Grothusen JR.
    Brain Res; 1992 Aug 21; 588(2):261-9. PubMed ID: 1356591
    [Abstract] [Full Text] [Related]

  • 10. L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.
    Jolkkonen J, Jenner P, Marsden CD.
    Brain Res Mol Brain Res; 1995 Sep 21; 32(2):297-307. PubMed ID: 7500841
    [Abstract] [Full Text] [Related]

  • 11. Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography.
    Javitch JA, Strittmatter SM, Snyder SH.
    J Neurosci; 1985 Jun 21; 5(6):1513-21. PubMed ID: 4009243
    [Abstract] [Full Text] [Related]

  • 12. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
    Graybiel AM, Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW.
    Adv Neurol; 1993 Jun 21; 60():34-9. PubMed ID: 8420148
    [No Abstract] [Full Text] [Related]

  • 13. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G, Jenner P.
    Brain Res; 2003 Apr 11; 968(2):206-18. PubMed ID: 12663090
    [Abstract] [Full Text] [Related]

  • 14. Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
    Graham WC, Hill DR, Woodruff GN, Sambrook MA, Crossman AR.
    Neurosci Lett; 1991 Sep 30; 131(1):129-34. PubMed ID: 1791971
    [Abstract] [Full Text] [Related]

  • 15. GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.
    Iravani MM, Costa S, Jackson MJ, Tel BC, Cannizzaro C, Pearce RK, Jenner P.
    Eur J Neurosci; 2001 Feb 30; 13(3):597-608. PubMed ID: 11168568
    [Abstract] [Full Text] [Related]

  • 16. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW, Graybiel AM.
    Proc Natl Acad Sci U S A; 1992 May 01; 89(9):3859-63. PubMed ID: 1570304
    [Abstract] [Full Text] [Related]

  • 17. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM.
    Neuroscience; 1995 Aug 01; 67(3):631-47. PubMed ID: 7675192
    [Abstract] [Full Text] [Related]

  • 18. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.
    Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626
    [Abstract] [Full Text] [Related]

  • 19. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.
    Chinaglia G, Alvarez FJ, Probst A, Palacios JM.
    Neuroscience; 1992 Jul 01; 49(2):317-27. PubMed ID: 1436470
    [Abstract] [Full Text] [Related]

  • 20. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
    Tanji H, Araki T, Nagasawa H, Itoyama Y.
    Brain Res; 1999 Apr 10; 824(2):224-31. PubMed ID: 10196452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.